Gene · 51744
Papers3,665
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,665
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cytotoxic CD4+ T cells: origin, biological functions, diseases and therapeutic targets. | Signal Transduct Target Ther | 2026 | 41803090 | PubTator, text mining | PubMed |
| Preclinical advances and mechanistic insights of CAR-T therapy for acute myeloid leukemia: from target iteration to microenvironment regulation. | Ann Med | 2026 | 41800605 | PubTator, text mining | PubMed |
| Balancing Intrinsic and Extrinsic Factors in CD8+ T Cell Therapy. | Immune Netw | 2026 | 41800029 | PubTator, text mining | PubMed |
Active Macropinocytosis, Lipid Catabolism, and Exhausting Immune Microenvironment of Ascites Tumor Cells Are Involved in Resistance to Platinum-Based Therapy in Patients With High-Grade Serous Ovarian Cancer. | MedComm (2020) | 2026 | 41799929 | PubTator, text mining | PubMed |
| Olink proteomics identifies FGF-19 as a treatment-responsive inflammatory biomarker associated with acupuncture intervention in young females with mild depression. | Front Psychiatry | 2026 | 41799812 | PubTator, text mining | PubMed |
| NKG2A+ NK cell cytotoxicity of Epstein-Barr virus infected B cells is mediated through the NKG2D and NKp30 activating receptors. | J Immunol | 2026 | 41795284 | PubTator, text mining | PubMed |
| Immune Exhaustion in Chronic Infection and Cancer: Signaling Pathways and Therapeutic Interventions. | MedComm (2020) | 2026 | 41768369 | PubTator, text mining | PubMed |
| Construction of circadian clock signature for tumor microenvironment in predicting survival of esophageal squamous cell carcinoma. | Front Immunol | 2026 | 41766897 | PubTator, text mining | PubMed |
| IFNγ/JAK/STAT1/CD38 pathway in SH2D1Bhigh NK cells: Implications for inflammation in type 1 diabetes. | J Immunol | 2026 | 41764744 | PubTator, text mining | PubMed |
| COVID-19 boosters restore virus-specific immune responses in kidney transplant recipients unresponsive to primary vaccination. | Npj Viruses | 2026 | 41760864 | PubTator, text mining | PubMed |
| Differentiating Multisystem Inflammatory Syndrome in Children (MIS-C) from Acute COVID-19 Using Biomarkers: Toward a Practical Clinical Scoring Model. | Biomedicines | 2026 | 41751157 | PubTator, text mining | PubMed |
| Engineering Bi-Specific CAR-NK Cells to Restore Antibody-Dependent Cellular Cytotoxicity in Solid Tumors. | Cells | 2026 | 41744817 | PubTator, text mining | PubMed |
| Association of Inflammatory Proteins with Neuropathic Pain: A Two-Sample Bidirectional Mendelian Randomization. | J Pain Res | 2026 | 41737298 | PubTator, text mining | PubMed |
| The tumor microenvironment in leukemia: molecular pathways of immune evasion. | Front Immunol | 2026 | 41727472 | PubTator, text mining | PubMed |
| Proteomic Insights into Venous Thromboembolism. | Med Sci (Basel) | 2026 | 41718141 | PubTator, text mining | PubMed |
| Transcriptomic and functional evidence reveals dual-module immune response of human-nasal staphylococcus aureus in Koi Carp (Cyprinus carpio). | Int J Med Microbiol | 2026 | 41687281 | PubTator, text mining | PubMed |
| A cross-sectional examination of immune adaptations during pregnancy in the ECHO Cohort. | bioRxiv | 2026 | 41676523 | PubTator, text mining | PubMed |
| T Cell Exhaustion in Hepatocellular Carcinoma: A Substantial Barrier in Immunotherapy. | J Cell Mol Med | 2026 | 41645702 | PubTator, text mining | PubMed |
| Multi-Omics Analysis of Human Blood Cells Reveals Unique Features of Age-Associated Type 2 CD8 Memory T Cells. | Aging Cell | 2026 | 41622514 | PubTator, text mining | PubMed |
| Multimodal digital biopsy for preoperative prediction of occult peritoneal metastasis in gastric cancer. | NPJ Digit Med | 2026 | 41588105 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51744/papers?page=2